DS
TIL icon

David Shaw’s Instil Bio TIL Stock Holding History

David Shaw’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,808
Closed -$853K – 5122
2022
Q3 		$853K Sell
8,808
-3,968
-31% -$454K ﹤0.01% 3703
2022
Q2 		$1.18M Buy
12,776
+11,104
+664% +$1.57M ﹤0.01% 3513
2022
Q1 		$359K Buy
1,672
+1,141
+215% +$267K ﹤0.01% 4563
2021
Q4 		$182K Buy
+531
New +$205K ﹤0.01% 4915
2021
Q3 		– Sell
-2,123
Closed -$820K – 5237
2021
Q2 		$820K Buy
+2,123
New +$787K ﹤0.01% 3708

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's TIL Position: Q4 2022 in Review

David Shaw sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 8,808 shares — an estimated $853K sold.

David Shaw first reported a position in TIL in Q2 2021 and held it in 5 quarters. The position peaked at $1.18M in Q2 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • David Shaw reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 8,808 Instil Bio shares in Q4 2022, an estimated $853K.
  • David Shaw first reported a position in Instil Bio in Q2 2021 and held it in 5 quarters.
  • David Shaw's Instil Bio position peaked at $1.18M in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.